P-Values on Trial: Selective Reporting of (Best Practice Guides Against) Selective Reporting
From The Embassy of Good Science
Revision as of 08:06, 22 October 2020 by 0000-0003-3048-2023 (talk | contribs) (Created page with "{{Resource |Resource Type=Cases |Title=P-Values on Trial: Selective Reporting of (Best Practice Guides Against) Selective Reporting |Is About=This study presented a legal case...")
ResourcesCases
P-Values on Trial: Selective Reporting of (Best Practice Guides Against) Selective Reporting
What is this about?
This study presented a legal case from 2009, when the U.S. Supreme Court found guilty of fraud Scott Harkonen, CEO of drug company InterMune. Harkonen reported that a drug Actimmune had statistically significant survival benefits, when in reality it did not.
